Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Pharmaceutics|July 30, 2025
Advances in Nano-Drug Delivery for Tumor Microenvironment and Drug Resistance-Insights from the Special Issue "Nano-Drug Delivery Systems for Targeting the Tumor Microenvironment and Simultaneously Overcoming Drug Resistance Properties"Patrícia M A Silva, Odília QueirósInternational Journal of Molecular Sciences|June 26, 2025
Advances in Bioactive Compounds and Cancer Therapy-Insights from the Special Issue "Bioactive Compounds in Cancers"Hassan Bousbaa, Honorina Cidade, Patrícia M A SilvaFEBS Letters|November 4, 2015
Co-silencing of human Bub3 and dynein highlights an antagonistic relationship in regulating kinetochore-microtubule attachmentsPatrícia M A Silva, Álvaro A Tavares, Hassan BousbaaCurrent Cancer Drug Targets|March 4, 2015
Targeting the spindle assembly checkpoint for breast cancer treatmentSandra Marques, Joana Fonseca, Patrícia M A Silva, et al.International Journal of Molecular Sciences|September 27, 2025
Kinesin Spindle Protein (KIF11) in Mitosis and CancerJoão P N Silva, Patrícia M A Silva, Hassan BousbaaPharmaceutics|November 25, 2023
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug ResistanceAndrea Cunha, Patrícia M A Silva, Bruno Sarmento, et al.Clinical Colorectal Cancer|July 21, 2016
Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future PerspectivesVânia Diogo, Joana Teixeira, Patrícia M A Silva, et al.Pharmaceutics|August 10, 2021
Second-Generation Antimitotics in Cancer Clinical TrialsPedro Novais, Patrícia M A Silva, Isabel Amorim, et al.Pharmaceutics|December 9, 2020
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer ResearchBárbara Pinto, Ana C Henriques, Patrícia M A Silva, et al.Pageof 5